April 4, 2018 / 6:22 AM / 8 months ago

BRIEF-Oryzon Genomics Gets Approval In Spain To Start Phase IIa Clinical Trial In Alzheimer's Disease With ORY-2001

April 4 (Reuters) - Oryzon Genomics SA:

* GETS APPROVAL TO START ETHERAL: A PHASE IIA CLINICAL TRIAL IN ALZHEIMER’S DISEASE WITH ORY-2001

* EXPECTS TO START PATIENT ENROLLMENT THIS QUARTER

* FIRST APPROVAL RECEIVED FROM AEMPS IN SPAIN, APPROVALS FROM OTHER EUROPEAN AGENCIES EXPECTED SOON

* AIMS TO LAUNCH A TWIN STUDY IN THE US WITH A NUMBER OF ADDITIONAL PATIENTS Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below